Market Snapshot

BSE Sensex: 74106.85 1.07%
BSE 500: 33229.93 1.19%
BSE 200: 10469.4 1.18%
BSE 100: 24118.5 1.14%
BSE BANKEX: 59184.25 2.03%
BSE IT: 29460.05 0.59%
Nifty 50: 22968.25 1.12%
Nifty 500: 21194.05 1.22%
Nifty 200: 12886.4 1.24%
Nifty 100: 23579.45 1.18%
Nifty Midcap 100: 54492.65 1.52%
Nifty Small 100: 15853.05 1.29%
Nifty IT: 30636.55 0.64%
Nifty PSU Bank: 8323.95 2.33%

News:

PNGS Reva Diamond Jewellery ga...
AWL Agri Business clocks doubl...
AU Small Finance Bank rises as...
KNR Constructions Ltd leads lo...
NMDC climbs after hiking iron ...

Pharmaids Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

06 Apr 2026 | 03:59 PM

30.83

-0.06 (-0.19%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-55.08%

Return (1Y)

Underperformed BSE Sensex by 56.4%
More Volatile

2.96%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.11%
Inconsistent Performer

3/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Pharmaids Pharmaceuticals announces divestment of step-down subsidiary
10 days ago

Pharmaids Pharmaceuticals announces divestment of step-down subsidiary

28 - Mar - 2026 12:00 | 10 days ago

Pharmaids Pharmaceuticals announced the disinvestment/sale of shareholding in Siri Labvivo Diet (the company's step-down subsidiary) by Adita Bio Sys (the company's material subsidiary).
Consequent to the completion of the above transaction, Siri Labvivo Diet has ceased to be a subsidiary of Adita Bio Sys and accordingly, has also ceased to be a step-down subsidiary of the Company with effect from 27 March 2026.
Powered by Capital Market - Live News
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the December 2025 quarter
53 days ago

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the December 2025 quarter

13 - Feb - 2026 12:00 | 53 days ago

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.48 crore in the quarter ended December 2025 as against net loss of Rs 1.93 crore during the previous quarter ended December 2024. Sales rose 15.29% to Rs 5.43 crore in the quarter ended December 2025 as against Rs 4.71 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 5.43 4.71 15

OPM % -46.22 -61.36 -

PBDT -3.15 -3.36 6

PBT -3.62 -4.00 10

NP -2.48 -1.93 -28

Powered by Capital Market - Live News
Pharmaids Pharmaceuticals schedules board meeting
57 days ago

Pharmaids Pharmaceuticals schedules board meeting

09 - Feb - 2026 12:00 | 57 days ago

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2026.
Powered by Capital Market - Live News
Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the September 2025 quarter
146 days ago

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.48 crore in the September 2025 quarter

12 - Nov - 2025 12:00 | 146 days ago

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.48 crore in the quarter ended September 2025 as against net loss of Rs 1.93 crore during the previous quarter ended September 2024. Sales rose 64.31% to Rs 8.61 crore in the quarter ended September 2025 as against Rs 5.24 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 8.61 5.24 64

OPM % -61.79 -45.99 -

PBDT -6.18 -2.73 -126

PBT -6.65 -3.34 -99

NP -2.48 -1.93 -28

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Promoter shareholding in Pharmaids Pharmaceuticals Ltd has increased by 532.17% since past 1 Year
Pharmaids Pharmaceuticals Ltd has the Lowesr P/E ratio according to FY 202503 data among stocks in Pharmaceuticals Sector
Pharmaids Pharmaceuticals Ltd has the Lowesr P/B ratio according to FY 202503 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	5.43	4.71	15
OPM %	-46.22	-61.36	-
PBDT	-3.15	-3.36	6
PBT	-3.62	-4.00	10
NP	-2.48	-1.93	-28

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	8.61	5.24	64
OPM %	-61.79	-45.99	-
PBDT	-6.18	-2.73	-126
PBT	-6.65	-3.34	-99
NP	-2.48	-1.93	-28

General Notifications

My Notifications

Research Notifications

Pharmaids Pharmaceuticals Ltd Share Price – BSE Pharmaceuticals, Small Cap

30.83 -0.06 (-0.19%)

News & Announcements

Price vs Volume

Stock Trivia

Pharmaids Pharmaceuticals Ltd Share Price – BSE
Pharmaceuticals, Small Cap

30.83

-0.06 (-0.19%)